Benefits of NAT (Nucleic acid amplification testing) testing of blood "could be replicated for tissue"
This article was originally published in Clinica
Using genetic tests to identify infectious diseases has made the US blood supply much safer in recent years, and could do much the same for donated tissue, public health officials reported last week.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.